Smoking cessation and nicotine de-addiction drugs are used in the treatment of withdrawal symptoms associated with cessation of tobacco. The World Health Organization (WHO) estimates that tobacco kills around 6 million people each year out of these almost 5 million deaths are result of direct tobacco use and approximately 600,000 deaths are due to passive tobacco smoking which is the result of nonsmokers getting exposed to tobacco smoke. Tobacco takes a toll on the income of people belonging to poor countries and also adds to the existing high healthcare cost and hinders economic development.
Nicotine use is accompanied by the risk factor for diseases and disorders such as cardiovascular diseases, cancer, neurological disorders, hypertension etc. WHO has also stated that tobacco quitting assistance in form of National cessation services with cost-coverage are available in only 24 countries, representing 15% of the global population. Only 42 countries which comprises of 19% of the world’s population, have instituted advertisement regulations such as pictorial warnings.
- Pfizer Inc
- VMR Products LLC
- Johnson & Johnson
- Novartis International AG
- Cipla Inc.
- GlaxoSmithKline plc.
- Nicotek LLC.
- Lorillard, Inc
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2737
Other market driving factors for smoking cessation and nicotine de-addiction products include increasing awareness of the ill effects of smoking and active role of social and health organizations against tobacco use, the high costs of tobacco products, social stigma imposed on tobacco users, growing regulations against tobacco use etc. However, the most critical factor is the huge number of unmet needs of around millions of smokers in Middle East and Africa nations.
The market’s restraints include the tradition of tobacco use being associated with maleness and the relapse rates of people who are not able to quit tobacco. The market’s trends include development of better products such as nicotine gums and patches, e-cigarette’s etc.
Middle East and Africa Smoking Cessation and Nicotine de-addiction Market:
The Middle East and Africa smoking cessation & nicotine de-addiction market has been evaluated to be a growing market and is expected to grow at a moderate CAGR of 12.5% in future. The growth will be primarily channeled by unmet medical needs and growth of awareness about side effects associated with smoking in Africa. Growth of smoking cessation and nicotine de-addiction centers is also driving the market.
Depending on geographic region, smoking cessation and nicotine de-addiction market is segmented into following countries which includes UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. However, the future market will be led by poorly developed parts of Africa due to large unmet needs and growing awareness about tobacco ill effects.
Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies and others. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is again segmented into pharmacies, online and de-addiction centers.
– Smoking cessation and nicotine de-addiction products manufacturers
– Smoking cessation and nicotine de-addiction products suppliers
– Market research and consulting service providers
– De-Addiction centers
The global E-Cigarettes & Vaporizer market is expected to grow at a CAGR over 25.0% over the period of 2016 to 2021 https://www.marketresearchfuture.com/reports/global-e-cigarette-vaporizer-market-949
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India